These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33374094)

  • 81. Insulin pumps in children - a systematic review.
    Al-Beltagi M; Saeed NK; Bediwy AS; Elbeltagi R
    World J Clin Pediatr; 2022 Nov; 11(6):463-484. PubMed ID: 36439904
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Insulin pump therapy in children and teenagers].
    Bergholtz CH; Olsen B; Johannesen J
    Ugeskr Laeger; 2009 Jun; 171(23):1913-8. PubMed ID: 19500513
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
    Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Insulin doses before and one year after pump start: children have a reversed dawn phenomenon.
    Nicolajsen T; Samuelsson A; Hanas R
    J Diabetes Sci Technol; 2012 May; 6(3):589-94. PubMed ID: 22768890
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
    Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
    Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
    Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials.
    Ostrovski I; Lovblom LE; Scarr D; Weisman A; Cardinez N; Orszag A; Falappa CM; D'Aoust É; Haidar A; Rabasa-Lhoret R; Legault L; Perkins BA
    Can J Diabetes; 2020 Apr; 44(3):229-235. PubMed ID: 31630987
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.
    Schiel R; Burgard D; Perenthaler T; Stein G; Kramer G; Steveling A
    Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):99-104. PubMed ID: 26895277
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 92. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes.
    Danne T; Bangstad HJ; Deeb L; Jarosz-Chobot P; Mungaie L; Saboo B; Urakami T; Battelino T; Hanas R;
    Pediatr Diabetes; 2014 Sep; 15 Suppl 20():115-34. PubMed ID: 25182312
    [No Abstract]   [Full Text] [Related]  

  • 93. Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.
    Grunberger G; Abelseth JM; Bailey TS; Bode BW; Handelsman Y; Hellman R; Jovanovič L; Lane WS; Raskin P; Tamborlane WV; Rothermel C
    Endocr Pract; 2014 May; 20(5):463-89. PubMed ID: 24816754
    [No Abstract]   [Full Text] [Related]  

  • 94. Reassessment of insulin dosing guidelines in continuous subcutaneous insulin infusion treated type 1 diabetes.
    King AB
    Curr Diab Rep; 2014 Jun; 14(6):503. PubMed ID: 24792068
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty.
    Cemeroglu AP; Thomas JP; Zande LT; Nguyen NT; Wood MA; Kleis L; Davis AT
    Endocr Pract; 2013; 19(5):805-11. PubMed ID: 23757622
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.